End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24,650 KRW | +2.07% | +5.12% | +3.35% |
2023 | CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index | CI |
Sales 2021 | 142B 103M 0 | Sales 2022 | 156B 113M 0 | Capitalization | 131B 94.92M 0 |
---|---|---|---|---|---|
Net income 2021 | -6.58B -4.78M - | Net income 2022 | -16.7B -12.14M - | EV / Sales 2021 | 2.36 x |
Net Debt 2021 | 106B 76.95M 0 | Net Debt 2022 | 126B 91.75M 0 | EV / Sales 2022 | 1.65 x |
P/E ratio 2021 |
-34.9
x | P/E ratio 2022 |
-7.82
x | Employees | 519 |
Yield 2021 |
0.24% | Yield 2022 |
-
| Free-Float | 60.84% |
1 day | +2.07% | ||
1 week | +5.12% | ||
Current month | +2.92% | ||
1 month | +2.92% | ||
3 months | +7.64% | ||
6 months | +23.87% | ||
Current year | +3.35% |
Managers | Title | Age | Since |
---|---|---|---|
Jeong-Jin Lee
CEO | Chief Executive Officer | 59 | - |
Jin-Hyo Jung
BRD | Director/Board Member | 62 | 15-03-19 |
Han-Joon Kim
PRN | Corporate Officer/Principal | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jang-Han Lee
PRN | Corporate Officer/Principal | 71 | - |
Jeong-Jin Lee
CEO | Chief Executive Officer | 59 | - |
Jin-Hyo Jung
BRD | Director/Board Member | 62 | 15-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 24,650 | +2.07% | 14,710 |
24-04-26 | 24,150 | +2.55% | 13,360 |
24-04-25 | 23,550 | -0.21% | 7,553 |
24-04-24 | 23,600 | -0.21% | 7,801 |
24-04-23 | 23,650 | +0.85% | 4,449 |
End-of-day quote Korea S.E., April 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.35% | 96.25M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- A063160 Stock